House Committee Report
Underlined text would be added to current law. Struck-through text would be removed.
| 89R9499 EAS-F | ||
| By: Capriglione, Orr | H.B. No. 2295 |
| A BILL TO BE ENTITLED | |
| AN ACT | |
| relating to newborn screening tests for Duchenne muscular | |
| dystrophy. | |
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | |
| SECTION 1. The heading to Chapter 33, Health and Safety | |
| Code, is amended to read as follows: | |
| CHAPTER 33. DUCHENNE MUSCULAR DYSTROPHY, PHENYLKETONURIA, OTHER | |
| HERITABLE DISEASES, HYPOTHYROIDISM, AND CERTAIN OTHER DISORDERS | |
| SECTION 2. Section 33.001, Health and Safety Code, is | |
| amended by adding Subdivision (6) to read as follows: | |
| (6) "Duchenne muscular dystrophy" means a progressive | |
| muscular degeneration disorder caused by alterations of the protein | |
| dystrophin and characterized by progressive muscle degeneration | |
| and weakness. | |
| SECTION 3. Sections 33.002(a) and (c), Health and Safety | |
| Code, are amended to read as follows: | |
| (a) The department shall carry out a program to combat | |
| morbidity, including intellectual disability, and mortality in | |
| persons who have Duchenne muscular dystrophy, phenylketonuria, | |
| other heritable diseases, or hypothyroidism. | |
| (c) The department shall establish and maintain a | |
| laboratory to: | |
| (1) conduct experiments, projects, and other | |
| activities necessary to develop screening or diagnostic tests for | |
| the early detection of Duchenne muscular dystrophy, | |
| phenylketonuria, other heritable diseases, and hypothyroidism; | |
| (2) develop ways and means or discover methods to be | |
| used to prevent or treat Duchenne muscular dystrophy, | |
| phenylketonuria, other heritable diseases, and hypothyroidism; and | |
| (3) serve other purposes considered necessary by the | |
| department to carry out the program. | |
| SECTION 4. Section 33.011(a), Health and Safety Code, is | |
| amended to read as follows: | |
| (a) The physician attending a newborn child or the person | |
| attending the delivery of a newborn child that is not attended by a | |
| physician shall cause the child to be subjected to screening tests | |
| approved by the department for Duchenne muscular dystrophy, | |
| phenylketonuria, other heritable diseases, hypothyroidism, and | |
| other disorders for which screening is required by the department. | |
| SECTION 5. Section 33.014(a), Health and Safety Code, is | |
| amended to read as follows: | |
| (a) If, because of an analysis of a specimen submitted under | |
| Section 33.011, the department reasonably suspects that a newborn | |
| child may have Duchenne muscular dystrophy, phenylketonuria, | |
| another heritable disease, hypothyroidism, or another disorder for | |
| which the screening tests are required, the department shall notify | |
| the person who submits the specimen that the results are abnormal | |
| and provide the test results to that person. The department may | |
| notify one or more of the following that the results of the analysis | |
| are abnormal and recommend further testing when necessary: | |
| (1) the physician attending the newborn child or the | |
| physician's designee; | |
| (2) the person attending the delivery of the newborn | |
| child that was not attended by a physician; | |
| (3) the parents of the newborn child; | |
| (4) the health authority of the jurisdiction in which | |
| the newborn child was born or in which the child resides, if known; | |
| or | |
| (5) physicians who are cooperating pediatric | |
| specialists for the program. | |
| SECTION 6. Section 33.031(a), Health and Safety Code, is | |
| amended to read as follows: | |
| (a) All newborn children and other individuals under 21 | |
| years of age who have been screened, have been found to be | |
| presumptively positive through the newborn screening program for | |
| Duchenne muscular dystrophy, phenylketonuria, other heritable | |
| diseases, hypothyroidism, or another disorder for which the | |
| screening tests are required, and may be financially eligible may | |
| be referred to the department's services program for children with | |
| special health care needs. | |
| SECTION 7. Section 33.032(a), Health and Safety Code, is | |
| amended to read as follows: | |
| (a) Within the limits of funds available for this purpose | |
| and in cooperation with the individual's physician, the department | |
| may provide services directly or through approved providers to | |
| individuals of any age who meet the eligibility criteria specified | |
| by department rules on the confirmation of a positive test for | |
| Duchenne muscular dystrophy, phenylketonuria, other heritable | |
| diseases, hypothyroidism, or another disorder for which the | |
| screening tests are required. | |
| SECTION 8. Section 203.355(c), Occupations Code, is amended | |
| to read as follows: | |
| (c) The laboratory services must include the performance of | |
| the standard serological tests for syphilis and the collection of | |
| blood specimens for newborn screening tests for Duchenne muscular | |
| dystrophy, phenylketonuria, hypothyroidism, and other heritable | |
| diseases as required by law. | |
| SECTION 9. Not later than September 1, 2027, the Department | |
| of State Health Services shall implement the changes in law made by | |
| this Act to the newborn screening program under Chapter 33, Health | |
| and Safety Code. | |
| SECTION 10. This Act takes effect September 1, 2025. |
Official text from the Texas Legislature. Formatting has been adapted for reading on Ratifi.